老年人由于身体机能的衰退以及慢性疾病的困扰，需要长期服用药物来控制疾病。心血管类药物则是老年人最常服用的一大类药。然而容易被忽略的是，在日常的饮食中，食物也有可能对药物产生影响，可以增强药效，也可能降低药效，甚至会引起不良反应。本文总结了不同的食物成 ...

2023年10月26日，首个完整的HIV-1长效注射治疗方案：万凯锐 (卡替拉韦)和瑞卡必 (利匹韦林),获中国国家药品监督管理局 (NMPA) 批准。该方案每两个月注射一次，不用与口服 ...

Most drugs are metabolized by CYP3A enzymes, and variations in expression levels of these enzymes are believed to determine whether patients will have a positive or adverse drug response.

瑞普替尼（Repotrectinib），商品名Augtyro，是一种新型的口服、小分子、多靶点的酪氨酸激酶抑制剂（TKI），主要用于治疗携带特定基因变异的晚期实体瘤，尤其是那些对现有治疗手段不再响应的患者。瑞普替尼的设计目标是克服由ALK（anaplastic lymphoma kinase）、ROS1（c-ros oncogene 1）和NTRK（neurotrophic tyrosine re ...

决奈达隆的商品名为Multaq ，是赛诺菲安万特公司开发的III 类抗心律失常药物。该药物于 2009 年 7 月获美国食品药品管理局 (FDA)批准。除了用于治疗心律失常外，它还被推荐作为胺碘酮的替代品，用于治疗心房颤动和心房扑动，适用于心脏已恢复正常节律或接受药物治疗或电击治疗，即直流电复律 (DCCV) 以维持正常节律的患者。

Because CYP isoenzymes metabolize a large number of structurally diverse drugs and chemicals, most of the variant genotypes of the CYP2D6, CYP2C9, CYP2C19, and CYP3A families have been identified ...

Avoid coadministration of GAVRETO with strong or moderate CYP3A inhibitors, P-gp inhibitors, or combined P-gp and strong or moderate CYP3A inhibitors. If coadministration cannot be avoided ...

Your body clears Xanax through a pathway known as cytochrome P450 3A (CYP3A). Medications that inhibit CYP3A4 make it harder for your body to break down Xanax, which increases your risk of overdosing.

CYP3A Inhibitors: When BRUKINSA is co-administered with a strong CYP3A inhibitor, reduce BRUKINSA dose to 80 mg once daily. For coadministration with a moderate CYP3A inhibitor, reduce BRUKINSA ...

Tabs: Avoid concomitant strong CYP3A inhibitors or P-gp inhibitors. Concomitant with moderate CYP3A inhibitors or P-gp inhibitors; monitor. Concomitant with sensitive CYP3A substrates (eg ...

A variety of researchers are converging on the view that human evolution has been shaped by gene–culture interactions. Theoretical biologists use models to demonstrate that cultural processes ...

Alprazolam 0.25mg, 0.5mg. 1mg, 2mg; scored tabs; orange flavor. ≥18yrs: Anxiety: Initially 0.25–0.5mg three times daily. May increase at 3–4 day intervals to 4mg/day in divided doses.